{"id":"NCT00289900","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)","officialTitle":"A Multicenter, Randomized, Double-Blind, Parallel Group, 12 Week Study to Evaluate the Efficacy and Safety of MK0524B Versus Atorvastatin in Patients With Mixed Hyperlipidemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-01-24","primaryCompletion":"2010-08-06","completion":"2010-08-06","firstPosted":"2006-02-10","resultsPosted":"2016-01-26","lastUpdate":"2018-08-31"},"enrollment":2340,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Mixed Hyperlipidemia"],"interventions":[{"type":"DRUG","name":"MK-0524A","otherNames":[]},{"type":"DRUG","name":"Atorvastatin","otherNames":["Lipitor"]},{"type":"DRUG","name":"Simvastatin","otherNames":["Zocor"]}],"arms":[{"label":"MK-0524B 2g/20 mg","type":"EXPERIMENTAL"},{"label":"MK-0524B 2g/40mg","type":"EXPERIMENTAL"},{"label":"Atorvastatin 10 mg","type":"ACTIVE_COMPARATOR"},{"label":"Atorvastatin 20 mg","type":"ACTIVE_COMPARATOR"},{"label":"Atorvastatin 40 mg","type":"ACTIVE_COMPARATOR"},{"label":"Atorvastatin 80 mg","type":"ACTIVE_COMPARATOR"}],"summary":"This is a 12-week clinical trial in participants with mixed hyperlipidemia to study the effects of MK-0524B on lipids.The primary hypothesis is that MK-0524B (dosed as MK-0524A coadministered with simvastatin) will be superior to atorvastatin on decreasing the low denisity lipoprotein cholesterol (LDL-C)/high-density lipoprotein cholesterol (HDL-C) ratio for the following dose comparisons: 2g/20 mg MK-0524B versus 10 mg atorvastatin, 2g/40 mg MK-0524B versus 20 mg atorvastatin, 2g/40 mg MK-0524B versus 40 mg atorvastatin, and 2g/40 mg MK-0524B versus 80 mg atorvastatin.","primaryOutcome":{"measure":"Percentage Change From Baseline in the LDL-C/HDL-C Ratio","timeFrame":"Baseline and Week 12","effectByArm":[{"arm":"MK-0524B 2g/20 mg","deltaMin":-50.9,"sd":null},{"arm":"MK-0524B 2g/40mg","deltaMin":-53,"sd":null},{"arm":"Atorvastatin 10 mg","deltaMin":-37.6,"sd":null},{"arm":"Atorvastatin 20 mg","deltaMin":-42.4,"sd":null},{"arm":"Atorvastatin 40 mg","deltaMin":-47.9,"sd":null},{"arm":"Atorvastatin 80 mg","deltaMin":-48.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG003","p":"<0.001"},{"comp":"OG001 vs OG004","p":"<0.001"},{"comp":"OG001 vs OG005","p":"0.007"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":5},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["22305632"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":297},"commonTop":["Flushing","Upper respiratory tract infection","Pruritus"]}}